Skip to main content Skip to navigation

Set the Pace of Health Equity

Together, we will secure a healthier future for everyone.

Global health is entering a period of instability: persistent inequalities in women’s health, the inevitability of future pandemics, and the rise of infections that don’t respond to antibiotics. Each is serious on its own, but together they show how fragile health systems can be and how much people suffer when responses are slow or uncoordinated.

Warwick is addressing these global challenges at their root. We are strengthening the entire research and policy pipeline – from developing leaders in women’s health, to advancing antibiotic discovery through equitable international partnerships, and building globally coordinated strategies for both pandemic planning and antimicrobial resistance.

Across these initiatives runs a common thread: experts from medicine, public health, mathematics, science, policy, and social science working together, and the deliberate cultivation of the next generation of global health leaders. Philanthropy is the catalyst that makes this long-term systemic approach possible – enabling sustained investment in discovery, leadership, and global coordination, and giving us the confidence to take on the greatest health challenges of our time.


The University of Warwick will play a catalytic role in the global effort to tackle antimicrobial resistance (AMR).


The Institute for Global Pandemic Planning combines world-class expertise in Mathematical Epidemiology, Public Health, and Behavioural Science.


Women spend 25% more of their lives in poor health, losing an average of nine years to debilitating conditions. Addressing these inequalities could add at least $1 trillion to the global economy annually by 2040.

Hear more about our projects

Let us know you agree to cookies